会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • EPOTHILONE DERIVATIVES AND METHODS FOR MAKING AND USING THE SAME
    • EPOTHILONE衍生物及其制备和使用方法
    • WO0192255A3
    • 2002-02-28
    • PCT/US0115763
    • 2001-05-15
    • KOSAN BIOSCIENCES INCSANTI DANIELFARDIS MARIAASHLEY GARY
    • SANTI DANIELFARDIS MARIAASHLEY GARY
    • C07D417/06C07D417/14C07D491/04C07D493/04A61K31/335A61P35/00
    • C07D417/06C07D417/14C07D491/04C07D493/04
    • The present invention relates to 16-membered macrocyclic compounds. In one aspect of the present invention, compounds of the formula (I), are provided wherein: R , R , R , and R are each independently hydrogen, methyl or ethyl; R is hydrogen, hydroxyl, oxo, or NRR' where R and R' are independently hydrogen, C1-C10 aliphatic, aryl or alkylaryl; R is hydrogen, oxo, or C1-C10 aliphatic, or optionally R and R together form a carbon-carbon double bond; R is hydrogen, hydroxyl, oxo, C1-C10 aliphatic, C1-C10 alkylester, or halide; R is hydrogen or C1-C10 aliphatic that is optionally substituted C1-C5 aliphatic, C1-C5 alkoxy, aryl, or a functional group selected from the group consisting of acetal, alcohol, aldehyde, amide, amine, carbamate, carboalkoxy, carbonate, carbodiimide, carboxylic acid, dioxolane and halogen, or optionally, R and R together form a 1,3-dioxane that is optionally substituted at the 2-position; R and R are both hydrogen or together form a carbon-carbon double bond or an epoxide; Ar is aryl; and, W is O or NR where R is hydrogen, C1-C10 aliphatic, aryl or alkylaryl provided that at least one of R , R , and R is not hydrogen. These compounds are cytotoxic agents and can be used to treat cancer and non-cancer disorders characterized by cellular hyperproliferation.
    • 本发明涉及16元大环化合物。 在本发明的一个方面,提供式(I)化合物,其中:R 1,R 2,R 3和R 10各自独立地为氢,甲基或乙基; R 4是氢,羟基,氧代或NRR',其中R和R'独立地是氢,C 1 -C 10脂族,芳基或烷基芳基; R 5是氢,氧代或C 1 -C 10脂族基,或任选地R 4和R 5一起形成碳 - 碳双键; R 6是氢,羟基,氧代,C 1 -C 10脂族,C 1 -C 10烷基酯或卤化物; R 7是氢或C 1 -C 10脂族基,其是任选取代的C 1 -C 5脂族,C 1 -C 5烷氧基,芳基或选自缩醛,醇,醛,酰胺,胺,氨基甲酸酯,烷氧羰基的官能团 ,碳酸酯,碳二亚胺,羧酸,二氧戊环和卤素,或任选地,R 6和R 7一起形成任选在2-位取代的1,3-二恶烷; R 8和R 9均为氢或一起形成碳 - 碳双键或环氧化物; Ar为芳基; 并且W是O或NR 11,其中R 11是氢,C 1 -C 10脂族,芳基或烷基芳基,条件是R 4,R 5和R 6中的至少一个不是氢 。 这些化合物是细胞毒性剂,可用于治疗以细胞过度增殖为特征的癌症和非癌症疾病。
    • 4. 发明申请
    • SIXTEEN-MEMBERED MACROLIDE COMPOUNDS
    • 第六届会议化妆品化学品
    • WO0232916A3
    • 2003-01-16
    • PCT/US0130725
    • 2001-09-24
    • KOSAN BIOSCIENCES INCKATZ LEONARDASHLEY GARYBURLINGAME MARK ADONG STEVEN DFU HONGLI YONGMYLES DAVID C
    • KATZ LEONARDASHLEY GARYBURLINGAME MARK ADONG STEVEN DFU HONGLI YONGMYLES DAVID C
    • A61P31/00C07D313/00C07H17/08A61K31/70C07C327/30
    • C07H17/08C07D313/00
    • The present invention provides novel sixteen-membered macrolide compounds that are useful as anti-infective agents or as intermediates thereto. The present invention also provides methods for the preparation of these compounds, and methods and formulations for their use. In one aspect of the present invention, sixteen-membered macrolide possessing a side chain Z are provided where Z is aliphatic, aryl, alkylaryl, halide, =NOR , =NNHR , or -W-R where W is O, S, NC(=O)R , NC(=O)OR , NC(=O)NHR or NR where R and R are each independently hydrogen, aliphatic, aryl or alkylaryl. In another aspect of the present invention, bicyclic compounds are provided where one of the cyclic-components is a sixteen-membered macrolide and the other is a cyclic moiety whose cyclic structure is formed by between 3 and 10 atoms. In another aspect of the present invention, sixteen-membered macrolide compounds that bind to the domain II region of the 23S RNA are provided.
    • 本发明提供可用作抗感染剂或作为其中间体的新颖的十六元大环内酯化合物。 本发明还提供了制备这些化合物的方法及其用途的方法和制剂。 在本发明的一个方面,提供了具有侧链Z的十六元大环内酯,其中Z是脂族,芳基,烷基芳基,卤化物,= NOR 3,= NNHR 3或-WR 3,其中W 是O,S,NC(= O)R 4,NC(= O)OR 4,NC(= O)NHR 4或NR 4,其中R 3和R 4是 各自独立地为氢,脂族,芳基或烷基芳基。 在本发明的另一方面,提供了双环化合物,其中环状组分之一是十六元大环内酯,另一个是其环状结构由3至10个原子形成的环状部分。 在本发明的另一方面,提供了结合23S RNA的结构域II的十六元大环内酯化合物。